xBrokers trading section officially launched, first stock "聚 (0XXXX.HK)" opens with a gain of over 462%
ChainCatcher News, according to the official announcement, on October 20, 2025, at 16:00 (UTC+8), the xBrokers trading zone officially launched its trial operation, with the first trading pair "Ju (0XXXX.HK)/HKDJ" going live simultaneously. The opening price was 4.999 HKDJ, rising to 28.103 HKDJ within one hour, an increase of approximately 462%. As of the time of publication, the trading volume in the first hour after launch exceeded 454,000 shares (equivalent to about 10.21 millions HKDJ).
Ju (0XXXX.HK) is the first real custodial Hong Kong stock in the xBrokers trading zone, which is 1:1 custodied by a licensed broker and recorded on-chain. Users can freely trade during the trial period and can withdraw the stock to any Hong Kong stock broker account after December 1. This marks the first time real Hong Kong stock assets have entered a crypto trading interface, injecting new liquidity and user participation channels into the Hong Kong stock market.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
A key leap toward the internationalization of the Korean won: The Bank of Korea launches a trial run of its 24/7 international settlement system, with full deployment set for January next year.
The Bank of Korea officially launched the trial operation of the "BOK Won International Payment Network" on Monday local time.
Offshore oil and gas module equipment company VME (VME.US) aiming for Nasdaq listing, plans to raise up to 30 million USD
Offshore oil and gas process module and separation equipment company VME Companies has applied for an IPO on Nasdaq, aiming to raise up to $30 million, with Kingswood as the sole bookrunner.
Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.
U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).
Pfizer (PFE.US) overseas price increase gains to be shared with the U.S. government: "Most Favored Nation" contract revealed, over twenty transactions still confidential
According to reports, under a new contract with the U.S. Department of Health and Human Services, Pfizer will share higher overseas drug revenues with the United States.
Crypto prices
More
